21 Americans Infected With Monkeypox
As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.
As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.
The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to happy tears.
MDMA-assisted treatment for post-traumatic stress disorder represents real hope for long-term healing, health experts say.
New treatments aim for a gene variant causing the illness in people of sub-Saharan African descent. Some experts worry that focus will neglect other factors.
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
A clinical trial will be needed to verify the research, which offered a warning about taking steroids or nonprescription drugs for weeks on end.
Medication abortion allows patients to terminate early pregnancies at home. Some states are moving to limit it, while others are working to expand access.
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefit and serious safety risks.
Efforts to tease apart the vast swarm of proteins in venom a field called venomics have burgeoned in recent years, leading to important drug discoveries.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Both antiviral treatments and monoclonal antibodies that treat Covid-19 are available across the city, but some public health experts worry that too few people know how to get them.
The consulting firms top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.